Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer

Authors

Upal Basu Roy, LUNGevity Foundation
Anne Marie Baird, Trinity College Dublin
Andrew Ciupek, GO2 Foundation for Lung Cancer
Jesme Fox, Roy Castle Lung Cancer Foundation
Eugene Manley, Lung Cancer Research Foundation
Kim Norris, XX, Lung Cancer Foundation of America
Giorgio V. Scagliotti, Università degli Studi di Torino
Heather A. Wakelee, Stanford UniversityFollow
Tetsuya Mitsudomi, Kindai University School of Medicine
Russell C. Clark, LLC
Renee Arndt, LLC
Fred R. Hirsch, Icahn School of Medicine at Mount Sinai
Paul A. Bunn, University of Colorado School of Medicine
Matthew P. Smeltzer, University of Memphis

Publication Title

JTO Clinical and Research Reports

Recommended Citation

Basu Roy, U., Baird, A., Ciupek, A., Fox, J., Manley, E., Norris, XX, K., Scagliotti, G., Wakelee, H., Mitsudomi, T., Clark, R., Arndt, R., Hirsch, F., Bunn, P., & Smeltzer, M. (2022). Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer. JTO Clinical and Research Reports, 3 (2) https://doi.org/10.1016/j.jtocrr.2021.100269